What values do the public want their health care systems to use in evaluating technologies?

Autor Buxton, Martin J., Chambers, James D.
Vydáno 2011

30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

Autor Leopold, Christine, Chambers, James D, Wagner, Anita K
Vydáno v J Pharm Policy Pract (2015)

Variation in health plan specialty drug coverage: an empirical analysis

Autor Margaretos, Nikoletta M., Lai, Rachel C., Panzer, Ari D., Chambers, James D.
Vydáno v J Drug Assess (2019)

Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs

Autor Chambers, James D., Silver, Madison C., Berklein, Flora C., Cohen, Joshua T., Neumann, Peter J.
Vydáno v J Gen Intern Med (2020)

Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans

Autor Chambers, James D., Lai, Rachel C., Margaretos, Nikoletta M., Panzer, Ari D., Cohen, Joshua T., Neumann, Peter J.
Vydáno v JAMA (2020)

EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS

Autor Chambers, James D., Saret, Cayla J., Anderson, Jordan E., Deverka, Patricia A., Douglas, Michael P., Phillips, Kathryn A.
Vydáno v Int J Technol Assess Health Care (2017)

Payer coverage policies for multigene tests

Autor Phillips, Kathryn A, Deverka, Patricia A, Trosman, Julia R, Douglas, Michael P, Chambers, James D, Weldon, Christine B, Dervan, Andrew P
Vydáno v Nat Biotechnol (2017)

An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review

Autor Chambers, James D., Naci, Huseyin, Wouters, Olivier J., Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron, Neumann, Peter J.
Vydáno v PLoS One (2015)

Correction: An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review

Autor Chambers, James D., Naci, Huseyin, Wouters, Olivier J., Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron, Neumann, Peter J.
Vydáno v PLoS One (2015)

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab

Autor Dusetzina, Stacie B., Ellis, Shellie, Freedman, Rachel A., Conti, Rena M., Winn, Aaron N., Chambers, James D., Alexander, G. Caleb, Huskamp, Haiden A., Keating, Nancy L.
Vydáno v J Oncol Pract (2015)

Insurance coverage for genomic tests

Autor Phillips, Kathryn A., Trosman, Julia R., Deverka, Patricia A., Quinn, Bruce, Tunis, Sean, Neumann, Peter J., Chambers, James D., Garrison, Louis P., Douglas, Michael P., Weldon, Christine B.
Vydáno v Science (2018)

The Decline in Vitamin Research Funding: A Missed Opportunity?

Autor Chambers, James D, Anderson, Jordan E, Salem, Mark N, Bügel, Susanne G, Fenech, Michael, Mason, Joel B, Weber, Peter, West, Keith P, Wilde, Parke, Eggersdorfer, Manfred, Booth, Sarah L
Vydáno v Curr Dev Nutr (2017)